36 JiangH.ChenY.LiM.XuX.WuG
thelancet.com/journals/landi Meta-analysis of 11 clinical trials showing that GLP-1 receptor agonists significantly reduce the risk of kidney outcomes, major adverse cardiovascular events, and all-cause death, without increasing the risk of serious adverse events such as hypoglycemia and acute pancreatitis
Abou-Khalil added that physicians could recommend ACV as part of lifestyle modifications for patients aiming to improve their metabolic health, alongside dietary changes and exercise. However, it's essential for physicians to counsel patients on proper dosage, potential side effects, and the importance of regular monitoring, especially for those on medication, he said
Pemafibrate, which improves liver pathology in diet-induced rodent model of NASH [58], will become a promising therapeutic agent for human NASH
It is formed by the same structures such as basal membrane, endothelial cells, astrocytes and pericytes
